shh.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Signs and symptoms in relation to progression, experiences of an uncertain illness situation in men with metastatic castration-resistant prostate cancer: A qualitative study
Sophiahemmet University.ORCID iD: 0000-0003-2074-5985
Sophiahemmet University.ORCID iD: 0000-0002-8780-5922
Show others and affiliations
2022 (English)In: European Journal of Cancer Care, ISSN 0961-5423, E-ISSN 1365-2354, Vol. 31, no 4, article id e13592Article in journal (Refereed) Published
Abstract [en]

OBJECTIVE: Signs and symptoms are important in monitoring prostate cancer, but there is a lack of understanding about the men's interpretation of signs and symptoms in relation to disease progression in advanced phases of the disease. The aim was to illuminate the experience of signs and symptoms in relation to disease progression in men with metastatic castration-resistant prostate cancer (mCRPC).

METHOD: Thirty longitudinal interviews were conducted with 11 men undergoing life-prolonging treatment for mCRPC. Conventional content analysis was used.

RESULTS: The results illuminate an uncertainty that the men experience when interpreting signs and symptoms. The overarching theme was The experience of an uncertain illness situation within the framework of progression, with four subthemes: Symptoms triggering thoughts about disease progression; Making sense of signs, also in the absence of symptoms; Making sense of symptoms during treatment; Progression triggering thoughts about the remainder of life.

CONCLUSION: In the uncertain illness situation, the men strive to make sense of signs and symptoms based on previous experiences and in relation to disease progression. Understanding the men's perspectives on signs and symptoms in this late phase may help health care professionals communicate about disease progression considering the balance between treatment outcome and quality of life.

Place, publisher, year, edition, pages
2022. Vol. 31, no 4, article id e13592
Keywords [en]
Metastatic castration-resistant prostate cancer, Prostate-specific antigen, Prostatic neoplasm, Qualitative research, Signs and symptoms, Uncertainty
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:shh:diva-4460DOI: 10.1111/ecc.13592PubMedID: 35411645OAI: oai:DiVA.org:shh-4460DiVA, id: diva2:1655752
Available from: 2022-05-03 Created: 2022-05-03 Last updated: 2022-08-31Bibliographically approved

Open Access in DiVA

fulltext(891 kB)182 downloads
File information
File name FULLTEXT01.pdfFile size 891 kBChecksum SHA-512
7f8c5e6ca0b7f21d52fa3f95f71d33c3820c844024eea44f6b6fc5f79eb20c7e62edbab5d2dcd2680f070212c4f87b46b6ab9fa720972a2d3829f493b9c02db2
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records

Holm, MajaDoveson, SandraWennman-Larsen, Agneta

Search in DiVA

By author/editor
Holm, MajaDoveson, SandraWennman-Larsen, Agneta
By organisation
Sophiahemmet University
In the same journal
European Journal of Cancer Care
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
Total: 182 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 275 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf